Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854. (Q33338241)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

25 July 2017

Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854. (English)

1 reference

Europe PubMed Central

25 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Bartlett NL

1

1 reference

Europe PubMed Central

25 July 2017

Petroni GR

2

1 reference

Europe PubMed Central

25 July 2017

Parker BA

3

1 reference

Europe PubMed Central

25 July 2017

Wagner ND

4

1 reference

Europe PubMed Central

25 July 2017

Gockerman JP

5

1 reference

Europe PubMed Central

25 July 2017

Omura GA

6

1 reference

Europe PubMed Central

25 July 2017

Canellos GP

7

1 reference

Europe PubMed Central

25 July 2017

Robert M

8

1 reference

Europe PubMed Central

25 July 2017

Johnson JL

9

1 reference

Europe PubMed Central

25 July 2017

Peterson BA

10

1 reference

Europe PubMed Central

25 July 2017

language of work or name

0 references

publication date

1 July 2001

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

92

1 reference

Europe PubMed Central

25 July 2017

2

1 reference

Europe PubMed Central

25 July 2017

207-217

1 reference

Europe PubMed Central

25 July 2017

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C207%3A%3AAID-CNCR1311%3E3.0.CO%3B2-D

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C207%3A%3AAID-CNCR1311%3E3.0.CO%3B2-D

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C207%3A%3AAID-CNCR1311%3E3.0.CO%3B2-D

21 January 2018

High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C207%3A%3AAID-CNCR1311%3E3.0.CO%3B2-D

21 January 2018

Dose-escalation of CHOP in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C207%3A%3AAID-CNCR1311%3E3.0.CO%3B2-D

21 January 2018

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C207%3A%3AAID-CNCR1311%3E3.0.CO%3B2-D

21 January 2018

International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C207%3A%3AAID-CNCR1311%3E3.0.CO%3B2-D

21 January 2018

Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C207%3A%3AAID-CNCR1311%3E3.0.CO%3B2-D

21 January 2018

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C207%3A%3AAID-CNCR1311%3E3.0.CO%3B2-D

21 January 2018

Vincristine, doxorubicin, cyclophosphamide, prednisone and etoposide (VACPE) in high-grade non-Hodgkin's lymphoma--a multicenter phase II study

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C207%3A%3AAID-CNCR1311%3E3.0.CO%3B2-D

21 January 2018

Adjuvant therapy of gastric cancer: have we made any progress?

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C207%3A%3AAID-CNCR1311%3E3.0.CO%3B2-D

21 January 2018

Phase I trial of dose escalation with growth factor support in patients with previously untreated diffuse aggressive lymphomas: determination of the maximum-tolerated dose of ProMACE-CytaBOM

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010715%2992%3A2%3C207%3A%3AAID-CNCR1311%3E3.0.CO%3B2-D

21 January 2018

Identifiers

10.1002/1097-0142(20010715)92:2<207::AID-CNCR1311>3.0.CO;2-D

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33338241&oldid=1610257037"